CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balances (in shares) at Dec. 31, 2022		29,493,193
Beginning Balances at Dec. 31, 2022	$ 558,393	$ 29,493	$ 387,171	$ 405,167	$ (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	20,807			20,807
Other Comprehensive Income (Loss)	32,946				32,946
Cash Dividends	(7,354)			(7,354)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		80,246
Restricted Share Grants Net	539	$ 80	459
Ending Balances (in shares) at Mar. 31, 2023		29,573,439
Ending Balances at Mar. 31, 2023	605,331	$ 29,573	387,630	418,620	(230,492)
Beginning Balances (in shares) at Dec. 31, 2022		29,493,193
Beginning Balances at Dec. 31, 2022	558,393	$ 29,493	387,171	405,167	(263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	42,930
Other Comprehensive Income (Loss)	14,586
Ending Balances (in shares) at Jun. 30, 2023		29,572,783
Ending Balances at Jun. 30, 2023	602,565	$ 29,573	388,460	433,384	(248,852)
Beginning Balances (in shares) at Mar. 31, 2023		29,573,439
Beginning Balances at Mar. 31, 2023	605,331	$ 29,573	387,630	418,620	(230,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	22,123			22,123
Other Comprehensive Income (Loss)	(18,360)				(18,360)
Cash Dividends	(7,359)			(7,359)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		(656)
Restricted Share Grants Net	830		830
Ending Balances (in shares) at Jun. 30, 2023		29,572,783
Ending Balances at Jun. 30, 2023	$ 602,565	$ 29,573	388,460	433,384	(248,852)
Beginning Balances (in shares) at Dec. 31, 2023	29,584,709	29,584,709
Beginning Balances at Dec. 31, 2023	$ 663,558	$ 29,585	389,411	461,622	(217,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	19,022			19,022
Other Comprehensive Income (Loss)	(19,895)				(19,895)
Cash Dividends	(7,955)			(7,955)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		84,310
Restricted Share Grants Net	524	$ 84	440
Ending Balances (in shares) at Mar. 31, 2024		29,669,019
Ending Balances at Mar. 31, 2024	$ 655,254	$ 29,669	389,851	472,689	(236,955)
Beginning Balances (in shares) at Dec. 31, 2023	29,584,709	29,584,709
Beginning Balances at Dec. 31, 2023	$ 663,558	$ 29,585	389,411	461,622	(217,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	39,552
Other Comprehensive Income (Loss)	$ (809)
Ending Balances (in shares) at Jun. 30, 2024	29,679,248	29,679,248
Ending Balances at Jun. 30, 2024	$ 687,821	$ 29,679	390,755	485,256	(217,869)
Beginning Balances (in shares) at Mar. 31, 2024		29,669,019
Beginning Balances at Mar. 31, 2024	655,254	$ 29,669	389,851	472,689	(236,955)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	20,530			20,530
Other Comprehensive Income (Loss)	19,086				19,086
Cash Dividends	(7,963)			(7,963)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		10,229
Restricted Share Grants Net	$ 914	$ 10	904
Ending Balances (in shares) at Jun. 30, 2024	29,679,248	29,679,248
Ending Balances at Jun. 30, 2024	$ 687,821	$ 29,679	$ 390,755	$ 485,256	$ (217,869)